Looking back at 4 years of development, KetoSwiss AG has finalised its product. In a next step, clinical trials will be conducted - we keep you posted.
Dr. Sebastian Hersberger joins KetoSwiss AG
June 1, 2019
The KetoSwiss team is enriched by Sebastian, an expert in business development and financial management, who joins KetoSwiss AG as Chief Operating Officer. Welcome!
KetoSwiss extents its portfolio to Alzheimer's
February 18, 2019
In addition to migraine, KetoSwiss will clinical test the efficacy of its lead product in Alzheimer's Disease with the first randomised controlled trial starting in summer 2019.
First pharmacokinetic trial completed
January 16, 2019
The first PK trial on healthy subjects has been completed, the second is starting soon.